Medication info
Kwangdong Atorvastatin Tablets 10 mg (Atorvastatin Calcium Trihydrate)

Kwangdong Atorvastatin Tablets 10 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Kwangdong Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200709787 · Notified 2007.08.24 · Insurance code 641800580

Summary

Main use
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Kwangdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction and stroke, and is effective in managing cardiovascular diseases such as vascular interventions and angina. Additionally, it regulates cholesterol and triglyceride levels in patients with hyperlipidemia and increases high-density lipoprotein (HDL) levels. It can be safely used in adult and pediatric patients with a family history or multiple risk factors. This medication plays an important role in improving cardiovascular health in conjunction with dietary therapy.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended starting dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or greater is required). This medication is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medication greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle problems, so if there is severe muscle pain or weakness, or a significant increase in creatine kinase levels, you must stop taking the medication immediately. Patients with impaired liver function or liver disease, women who are pregnant or may become pregnant, children, and individuals with certain genetic diseases should not use this medication. Patients with impaired liver or kidney function, older adults, and those with a history of muscle disorders should use this medication with caution, and it is important to have regular check-ups. During treatment, liver function and muscle condition should be monitored periodically, and if any unusual symptoms occur, you should consult a doctor immediately. This medication may interact with several other drugs, so if you are taking other medications, you must inform your doctor or pharmacist, especially when taken with certain antibiotics, antifungals, antivirals, or some heart medications. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraception while taking it. There is no specific antidote for overdose, so treatment should be symptomatic, and liver function and muscle enzyme levels should be monitored. Keep this medication out of the reach of children, and store it in its original container to prevent misuse or quality deterioration.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 168 more
  • loss of appetite
  • constipation
  • abdominal distention
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleeds
  • insomnia
  • nightmares
  • headache
  • dizziness
  • perceptual disturbances
  • sensory loss
  • taste disturbances
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive leukocytes in urine
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • obstructive jaundice
  • abnormal liver function test values
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • tension increase
  • myositis
  • muscle diseases
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • lethargy
  • vasomotor edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • nuchal rigidity
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • taste alteration
  • taste loss
  • taste distortion
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is best to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.